US 10066228
Oligonucleotides for treating expanded repeat diseases
granted A61PA61P21/02A61P21/04
Quick answer
US patent 10066228 (Oligonucleotides for treating expanded repeat diseases) held by Sarepta Therapeutics, Inc. expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P21/02, A61P21/04, A61P25/14, A61P25/28